Luehr, Gary W.,Sundaram, Arathi,Jaishankar, Priyadarshini,Payne, Philip W.,Druzgala, Pascal
申请号：
HRP20170134
公开号：
HRP20170134T1
申请日:
2017.01.26
申请国别(地区):
HR
年份:
2017
代理人:
摘要：
Provided are D 2 or D 3 antagonist compounds and pharmaceutical compositions of formula I and pharmaceutically acceptable salts thereof, or isomers thereof, wherein R 1 , R 2 and R 3 are as defined herein. The invention further comprises methods for making the compounds of the invention and methods for the treatment of conditions mediated by the dopamine D 2 or D 3 receptor from the compounds of the invention.
